Work

Abstract 6937: BCG046, a CDCP1 ADC that targets CTF, has demonstrated potent in vitro and in vivo efficacy

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-6937

Authors: Haochen Wei, Na Zhang, Chengzhang Shang, Yi Yang

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148656113

Cites:

Cited by:

Related to: